Chargement en cours...
Golimumab in adolescents with Crohn's disease refractory to previous tumour necrosis factor antibody
AIM: Anti‐tumour necrosis factor (TNF)‐α drugs are effective treatments for the management of moderate/severe Crohn's disease (CD), but treatment failure is common. In the treatment of paediatric CD, there are no data about the use of a third introduced subcutaneous TNF antibody golimumab. METH...
Enregistré dans:
| Publié dans: | Acta Paediatr |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7891654/ https://ncbi.nlm.nih.gov/pubmed/32781480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apa.15522 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|